2v5n: Difference between revisions

New page: left|200px<br /><applet load="2v5n" size="350" color="white" frame="true" align="right" spinBox="true" caption="2v5n, resolution 3.20Å" /> '''STRUCTURE OF HUMAN I...
 
No edit summary
 
(14 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:2v5n.jpg|left|200px]]<br /><applet load="2v5n" size="350" color="white" frame="true" align="right" spinBox="true"
caption="2v5n, resolution 3.20&Aring;" />
'''STRUCTURE OF HUMAN IGF2R DOMAINS 11-12'''<br />


==Overview==
==STRUCTURE OF HUMAN IGF2R DOMAINS 11-12==
Embryonic development and normal growth require exquisite control of, insulin-like growth factors (IGFs). In mammals the extracellular region of, the cation-independent mannose-6-phosphate receptor has gained an, IGF-II-binding function and is termed type II IGF receptor (IGF2R). IGF2R, sequesters IGF-II; imbalances occur in cancers and IGF2R is implicated in, tumour suppression. We report crystal structures of IGF2R domains 11-12, 11-12-13-14 and domains 11-12-13/IGF-II complex. A distinctive, juxtaposition of these domains provides the IGF-II-binding unit, with, domain 11 directly interacting with IGF-II and domain 13 modulating, binding site flexibility. Our complex shows that Phe19 and Leu53 of IGF-II, lock into a hydrophobic pocket unique to domain 11 of mammalian IGF2Rs., Mutagenesis analyses confirm this IGF-II 'binding-hotspot', revealing that, IGF-binding proteins and IGF2R have converged on the same high-affinity, site.
<StructureSection load='2v5n' size='340' side='right'caption='[[2v5n]], [[Resolution|resolution]] 3.20&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[2v5n]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2V5N OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2V5N FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.2&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2v5n FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2v5n OCA], [https://pdbe.org/2v5n PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2v5n RCSB], [https://www.ebi.ac.uk/pdbsum/2v5n PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2v5n ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/MPRI_HUMAN MPRI_HUMAN] Transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes. Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelyosomal compartment where the low pH mediates the dissociation of the complex. This receptor also binds IGF2. Acts as a positive regulator of T-cell coactivation, by binding DPP4.<ref>PMID:10900005</ref>
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/v5/2v5n_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2v5n ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Embryonic development and normal growth require exquisite control of insulin-like growth factors (IGFs). In mammals the extracellular region of the cation-independent mannose-6-phosphate receptor has gained an IGF-II-binding function and is termed type II IGF receptor (IGF2R). IGF2R sequesters IGF-II; imbalances occur in cancers and IGF2R is implicated in tumour suppression. We report crystal structures of IGF2R domains 11-12, 11-12-13-14 and domains 11-12-13/IGF-II complex. A distinctive juxtaposition of these domains provides the IGF-II-binding unit, with domain 11 directly interacting with IGF-II and domain 13 modulating binding site flexibility. Our complex shows that Phe19 and Leu53 of IGF-II lock into a hydrophobic pocket unique to domain 11 of mammalian IGF2Rs. Mutagenesis analyses confirm this IGF-II 'binding-hotspot', revealing that IGF-binding proteins and IGF2R have converged on the same high-affinity site.


==About this Structure==
Structure and functional analysis of the IGF-II/IGF2R interaction.,Brown J, Delaine C, Zaccheo OJ, Siebold C, Gilbert RJ, van Boxel G, Denley A, Wallace JC, Hassan AB, Forbes BE, Jones EY EMBO J. 2008 Jan 9;27(1):265-76. Epub 2007 Nov 29. PMID:18046459<ref>PMID:18046459</ref>
2V5N is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Known structural/functional Sites: <scene name='pdbsite=AC1:Nag Binding Site For Chain A'>AC1</scene> and <scene name='pdbsite=AC2:Nag Binding Site For Chain A'>AC2</scene>. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2V5N OCA].


==Reference==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
Structure and functional analysis of the IGF-II/IGF2R interaction., Brown J, Delaine C, Zaccheo OJ, Siebold C, Gilbert RJ, van Boxel G, Denley A, Wallace JC, Hassan AB, Forbes BE, Jones EY, EMBO J. 2007 Nov 29;. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=18046459 18046459]
</div>
<div class="pdbe-citations 2v5n" style="background-color:#fffaf0;"></div>
 
==See Also==
*[[Insulin-like growth factor receptor|Insulin-like growth factor receptor]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Boxel, G.Van.]]
[[Category: Brown J]]
[[Category: Brown, J.]]
[[Category: Delaine C]]
[[Category: Delaine, C.]]
[[Category: Denley A]]
[[Category: Denley, A.]]
[[Category: Forbes BE]]
[[Category: Forbes, B.E.]]
[[Category: Gilbert RJ]]
[[Category: Gilbert, R.J.]]
[[Category: Hassan AB]]
[[Category: Hassan, A.B.]]
[[Category: Jones EY]]
[[Category: Jones, E.Y.]]
[[Category: Siebold C]]
[[Category: Siebold, C.]]
[[Category: Wallace JC]]
[[Category: Wallace, J.C.]]
[[Category: Zaccheo OJ]]
[[Category: Zaccheo, O.J.]]
[[Category: Van Boxel G]]
[[Category: NAG]]
[[Category: beta barrel]]
[[Category: cation independent mannose 6-phosphate]]
[[Category: fibronectin type ii]]
[[Category: glycoprotein]]
[[Category: insulin-like growth factor]]
[[Category: lysosome]]
[[Category: membrane]]
[[Category: phosphorylation]]
[[Category: polymorphism]]
[[Category: receptor]]
[[Category: transmembrane]]
[[Category: transport]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 11:46:17 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA